Shaan Quadri’s vision for India Generics is simple and bold: remove the layers between manufacturers and retail pharmacies so essential, affordable medicines reach patients faster, reliably, and at lower cost. Drawing on his years in medical devices, hospital turnkey projects and healthcare e-commerce, Shaan understands both sides of the market — the manufacturer struggling with fragmented demand, unpredictable orders and tight margins, and the neighborhood retailer battling inconsistent supply, high procurement costs, and complex credit cycles.
India Generics is designed as a transparent, tech-driven B2B marketplace that directly links manufacturers and pharmacies, standardizes ordering, and brings volume economics to smaller buyers. By tackling real hurdles — distribution fragmentation, pricing opacity, minimum-order constraints, regulatory paperwork and last-mile logistics — the platform creates predictable demand for manufacturers and reliable, cost-effective supply for retailers.
The opportunity is huge: better margins for retailers, steadier production and faster inventory turns for manufacturers, fewer stockouts for patients, and overall lower healthcare costs. Shaan’s approach combines operational experience, on-ground partnerships and data insights to scale responsibly — turning a fragmented supply chain into a lean, trusted conduit for generic medicines across India.